BioSpace News Archive

Elligo Health Research, a leading integrated research organization with relationships and access to over 150 million patients and their data, announced its partnership with Laguna Clinical Research Associates.

Poster to highlight positive safety and efficacy signals demonstrated in ongoing proof-of-concept large animal study evaluating i-MSC stem cell therapy in acute lung injury

Use of Early Reading (ISIP ER) and Advanced Reading (ISIP AR) Istation technology shows student reading improvement in comparison to non-Istation users

Maxwell Biosciences Announces the CLAROMER ™ Brand Biotech Therapeutics Platform as It Advances Toward Clinical Trials

Serenus.AI ( www.serenusai.com ), an innovative startup developing AI-based solutions to improve medical treatment decisions, obtained a Notice of Allowance from the US Patent and Trademark Office that the application ‘AUTOMATED METHOD AND SYSTEM FOR SCREENING AND PREVENTION OF UNNECESSARY MEDICAL PROCEDURES’

Manufacturing is Expected to Expand in 2021; Revenue to Increase 7.2%; Capital Expenditures to Increase 8.7%; Capacity Utilization Currently at 88.3%; Services is Expected to Expand in 2021; Revenue to Increase 5.4%; Capital Expenditures to Increase 5.7%; Capacity Utilization Currently at 89.4%

Apollon Formularies plc and Aion Therapeutic Inc. are pleased to announce that joint testing has revealed their combined formulations to be effective in killing HER2+ breast cancer cells

Each Warrant is exercisable at a price of C$2.10 and entitles the holder thereof to acquire one common share of the Company for a period of 2 years following the closing of the Offering.

Results of 8th Peer-Reviewed Published Study of Celliant®, the Flagship Product of Hologenix®, a Materials Science Innovation Company, Published on Nature.com

As part of the employment agreement, and pursuant to the terms and conditions of the Company’s stock option plan, the PharmaDrug Board of Directors has approved the grant of 2,000,000 stock options to Paul Van Slyke.